Visionaries of Health podcast

Nicolas Wolikow

0:00
38:47
Manda indietro di 15 secondi
Manda avanti di 15 secondi

Learning From Cancer Survivors to Transform Oncology


In this episode of Visionaries of Health, Inga Bergen talks to Nicolas Wolikow, Co-Founder and CEO of Cure51 – a company on a mission to decode survival. Instead of focusing only on disease progression, Cure51 asks: Why do some people survive aggressive cancers – and what can we learn from them?

Nicolas shares how Cure51 collaborates with over 100 hospitals worldwide to identify so-called “Exceptional Survivors,” analyze their data, and use AI to find new therapeutic targets for cancers with very low survival rates. A powerful conversation about the future of oncology, the role of data in medicine – and how science and hope go hand in hand.

📌 This episode is in English.

Learn more about our podcast, all episodes, and your hosts – Inga Bergen & Larissa Middendorf – at:

🌐 www.visionaries-health.com

🎧 You’ll also find more inspiring conversations in our German podcast “Visionäre der Gesundheit”, available on all major podcast platforms.

📬 Want to suggest a topic or send us feedback?

Reach out anytime at: [email protected]

Altri episodi di "Visionaries of Health"